RESUMEN
The French Cancer Plan 2003-2007 has made translational research central to its research programme, to ensure the care-research continuum and the quickest application possible for the most recent discoveries, for the patients' benefit. This is a new field of research, still little-known or ill-understood. A working group, composed of physicians and researchers from academic research and industrial research, sought to define translational research in cancerology and define the issues at stake in it. Translational research needs to develop in close connection with the patients in order to enable a bi-directional flow of knowledge from cognitive research toward medical applications and from observations made on patients toward cognitive research. Placed under the aegis of the French National Cancer Institute and Leem Research, the group has put forth a strategy for implementing translational research in cancerology in France to make it attractive, competitive and efficient and to foster the development of public-private partnerships.
Asunto(s)
Investigación Biomédica/organización & administración , Difusión de Innovaciones , Neoplasias/terapia , Investigación Biomédica/normas , Francia , Humanos , Comunicación Interdisciplinaria , Modelos Animales , Neoplasias/genética , Participación del Paciente/métodosRESUMEN
DNA polymerase beta (Pol beta) is an error-prone enzyme whose up-regulation has been shown to be a genetic instability enhancer as well as a contributor to cisplatin resistance in tumor cells. In this work, we describe the isolation of new Pol beta inhibitors after high throughput screening of 8448 semipurified natural extracts. In vitro, the selected molecules affect specifically Pol beta-mediated DNA synthesis compared with replicative extracts from cell nuclei. One of them, masticadienonic acid (MA), is particularly attractive because it perturbs neither the activity of the purified replicative Pol delta nor that of nuclear HeLa cell extracts. With an IC50 value of 8 microM, MA is the most potent of the Pol beta inhibitors found so far. Docking simulation revealed that this molecule could substitute for single-strand DNA in the binding site of Pol beta by binding Lys35, Lys68, and Lys60, which are the main residues involved in the interaction Pol beta/single-strand DNA. Selected inhibitors also affect the Pol beta-mediated translesion synthesis (TLS) across cisplatin adducts; MA was still the most efficient. Therefore, masticadienonic acid sensitized the cisplatin-resistant 2008C13*5.25 human tumor cells. Our data suggest that molecules such as masticadienonic acid could be suitable in conjunction with cisplatin to enhance anticancer treatments.
Asunto(s)
Cisplatino/farmacología , ADN Polimerasa beta/antagonistas & inhibidores , ADN Polimerasa beta/metabolismo , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Animales , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Inhibidores Enzimáticos/aislamiento & purificación , Células HeLa , Humanos , Juniperus , Pistacia , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Hojas de la Planta , Tallos de la Planta , RatasRESUMEN
Exogenous FGF-2 added to cells is internalized and part of it translocates to the nucleus of the cells. To get a better understanding of the FGF-2-induced signaling pathway, we looked for proteins associated with FGF-2 in the cytoplasm of the target cells. We first used the GST-FGF-2 to isolate cytoplasmic proteins complexes containing FGF-2 from S100 extract (supernatant 100,000g). Among the retrieved proteins, we focused our studies on RPS19, a protein of the 40S small ribosomal subunit. We showed that FGF-2 interacts directly with RPS19 in vitro. Second, we coimmunoprecipitated RPS19 and FGF-2 from a S240 extract (240,000g supernatant) prepared from FGF-2-stimulated cells and devoid of 40S ribosomal subunit. The result of these experiments suggest that a pool of free RPS19 exists in cells and that FGF-2 interacts in vivo with free RPS19.
Asunto(s)
Factor 2 de Crecimiento de Fibroblastos/metabolismo , Proteínas Ribosómicas/metabolismo , Células 3T3 , Secuencia de Aminoácidos , Animales , Biotinilación , Northern Blotting , Cromatografía de Afinidad , Citoplasma/metabolismo , Relación Dosis-Respuesta a Droga , Factor 2 de Crecimiento de Fibroblastos/química , Eliminación de Gen , Glutatión Transferasa/metabolismo , Humanos , Ratones , Datos de Secuencia Molecular , Plásmidos/metabolismo , Pruebas de Precipitina , Unión Proteica , Proteínas Recombinantes/metabolismo , Proteínas Ribosómicas/química , Ribosomas/metabolismo , Transducción de SeñalRESUMEN
We carried out a high-resolution ultrastructural analysis of the nucleolus in mouse P815 cells by combining specific DNA and RNA staining, anti-fibrillarin immunolabeling, contrast enhancement by energy filtering TEM and phosphorus mapping by ESI to visualize nucleic acids. We demonstrated that specifically contrasted DNA, fibrillarin and phosphorus overlap within the nucleolar dense fibrillar component. Moreover, we describe a 'DNA cloud' consisting of an inner core of DNA fibers (fibrillar center) and a periphery made of extremely thin fibrils overlapping the anti-fibrillarin immunolabeling (dense fibrillar component). This highly sensitive approach has allowed us to demonstrate, for the first time, the exact distribution of DNA within the decondensed interphase counterpart of the NOR, which includes both the fibrillar center and the dense fibrillar component.
Asunto(s)
Región Organizadora del Nucléolo/fisiología , Región Organizadora del Nucléolo/ultraestructura , Animales , División Celular , Línea Celular , Proteínas Cromosómicas no Histona/metabolismo , ADN/metabolismo , ADN Ribosómico/metabolismo , Inmunohistoquímica , Ratones , Microscopía Electrónica , Modelos Biológicos , Unión Proteica , Transcripción GenéticaRESUMEN
Nucleolin is an abundant nucleolar protein involved in several steps of ribosome biogenesis. The protein is highly conserved through evolution and possesses four RNA-binding domains (RBD), which are likely to determine its RNA binding specificity. Previous studies have shown that nucleolin interacts with two different RNA targets. The first is a small stem-loop structure, the nucleolin recognition element (NRE), found all along the pre-ribosomal RNA. The second is a short single-stranded RNA sequence, the evolutionary conserved motif (ECM), located five nucleotides downstream of the first processing site in the pre-ribosomal RNA 5' external transcribed spacer. Biochemical, genetic, and structural studies have shown that the first two RBD of nucleolin are necessary and sufficient for the specific interaction of nucleolin with the NRE motif. In this work, we have studied the interaction of nucleolin with the ECM sequence. Deletion and mutational analyses showed that all four RBDs of hamster nucleolin were required for the interaction with the ECM sequence. This RNA binding specificity is conserved between hamster and Xenopus laevis, whereas the Xenopus protein does not interact with the NRE. Nucleolin is the first example of a protein that requires four RBDs for its interaction with an RNA target, demonstrating that a single protein can use different combinations of RBD to interact specifically with several RNA sequences.
Asunto(s)
Fosfoproteínas/química , Fosfoproteínas/metabolismo , Proteínas de Unión al ARN/química , Proteínas de Unión al ARN/metabolismo , ARN/metabolismo , Animales , Secuencia de Bases , Secuencia Conservada , Cricetinae , Análisis Mutacional de ADN , Relación Dosis-Respuesta a Droga , Eliminación de Gen , Cinética , Datos de Secuencia Molecular , Mutación , Fosfoproteínas/genética , Plásmidos/metabolismo , Unión Proteica , Conformación Proteica , Estructura Terciaria de Proteína , ARN Ribosómico/metabolismo , Proteínas de Unión al ARN/genética , Proteínas Recombinantes/metabolismo , Transcripción Genética , Rayos Ultravioleta , Xenopus , NucleolinaRESUMEN
The first processing event of the precursor ribosomal RNA (pre-rRNA) takes place within the 5' external transcribed spacer. This primary processing requires conserved cis-acting RNA sequence downstream from the cleavage site and several nucleic acids (small nucleolar RNAs) and proteins trans-acting factors including nucleolin, a major nucleolar protein. The specific interaction of nucleolin with the pre-rRNA is required for processing in vitro. Xenopus laevis and hamster nucleolin interact with the same pre-rRNA site and stimulate the processing activity of a mouse cell extract. A highly conserved 11-nucleotide sequence located 5-6 nucleotides after the processing site is required for the interaction of nucleolin and processing. In vitro selection experiments with nucleolin have identified an RNA sequence that contains the UCGA motif present in the 11-nucleotide conserved sequence. The interaction of nucleolin with pre-rRNA is required for the formation of an active processing complex. Our findings demonstrate that nucleolin is a key factor for the assembly and maturation of pre-ribosomal ribonucleoparticles.
Asunto(s)
Fosfoproteínas/metabolismo , ARN Ribosómico/metabolismo , Proteínas de Unión al ARN/metabolismo , Animales , Células CHO , Cricetinae , Matriz Extracelular/metabolismo , Ratones , Unión Proteica , Procesamiento Proteico-Postraduccional , ARN Ribosómico/genética , Proteínas Recombinantes/metabolismo , Xenopus laevis , NucleolinaRESUMEN
In situ sites of nucleolar transcription in cells microinjected with 5-bromo-UTP (BrUTP) were visualized at an ultrastructural level. After injection the cells were maintained for 4-90 min at 37 degrees C, fixed, and embedded in LR White resin. Postembedding immunoelectron microscopic visualization with colloidal gold has been used for localizing both Br-labeled precursor incorporated into pre-rRNA and different nucleolar transcription or processing factors. This high resolution approach allowed us to identify significant signal as early as after 4-min incubation periods following BrUTP microinjection. It revealed the dense fibrillar component (DFC) as being the first nucleolar compartment labeled with anti-bromodeoxyuridine antibody. Moreover, RNA polymerase I, nucleolar transcription factor UBF, and fibrillarin were also detected almost exclusively in this same nucleolar compartment. From 30 min onward, following microinjection, Br-labeled rRNA occurred also in the granular component. The results indicate that the DFC is the site of pre-rRNA transcription and of initial steps of pre-rRNA processing. Moreover, it demonstrates that BrUTP microinjection followed by postembedding detection of Br-labeled RNA is a useful technique for high resolution studies of structure-function associations in the nucleolus.
Asunto(s)
Nucléolo Celular/ultraestructura , Microscopía Inmunoelectrónica/métodos , Región Organizadora del Nucléolo/ultraestructura , Proteínas del Complejo de Iniciación de Transcripción Pol1 , Transcripción Genética , Uridina Trifosfato/análogos & derivados , Neoplasias de la Vejiga Urinaria/genética , Proteínas Cromosómicas no Histona/ultraestructura , Proteínas de Unión al ADN/ultraestructura , Humanos , Microinyecciones , ARN Polimerasa I/ultraestructura , Precursores del ARN/ultraestructura , ARN Ribosómico/ultraestructura , Ribonucleoproteínas/ultraestructura , Factores de Transcripción/ultraestructura , Células Tumorales Cultivadas/efectos de los fármacos , Uridina Trifosfato/administración & dosificación , Neoplasias de la Vejiga Urinaria/ultraestructuraRESUMEN
Sulfation is a major modification of many molecules in eukaryotes that is dependent on the enzymatic synthesis of an activated sulfate donor, 3'-phosphoadenosine 5'-phosphosulfate (PAPS). While sulfate activation has long been assumed to occur in the cytosol, we show in this study that human PAPS synthetase 1 (PAPSS1), a bifunctional ATP sulfurylase/adenosine 5'-phosphosulfate (APS) kinase enzyme sufficient for PAPS synthesis, accumulates in the nucleus of mammalian cells. Nuclear targeting of the enzyme is mediated by its APS kinase domain and requires a catalytically dispensable 21 amino acid sequence at the amino terminus. Human PAPSS1 and Drosophila melanogaster PAPSS localize to the nucleus in yeast and relieve the methionine auxotrophy of ATP sulfurylase- or APS kinase-deficient strains, suggesting that PAPSS1 is fully functional in vivo when targeted to the nucleus. A second PAPS synthetase gene, designated PAPSS2, has recently been described, mutations of which are responsible for abnormal skeletal development in human spondyloepimetaphyseal dysplasia and murine brachymorphism. We found that PAPSS2, which localizes to the cytoplasm when ectopically expressed in mammalian cells, is relocated to the nucleus when coexpressed with PAPSS1. Taken together, these results indicate that a sulfation pathway might exist in the nucleus of eukaryotic cells. -Besset, S., Vincourt, J.-B., Amalric, F., Girard, J.-P. Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells.
Asunto(s)
Núcleo Celular/metabolismo , Complejos Multienzimáticos/metabolismo , Proteínas Nucleares/metabolismo , Sulfato Adenililtransferasa/metabolismo , Sulfatos/metabolismo , Animales , Compartimento Celular , Citosol/metabolismo , Drosophila melanogaster , Células Eucariotas/enzimología , Prueba de Complementación Genética , Humanos , Complejos Multienzimáticos/genética , Señales de Localización Nuclear , Fosfotransferasas (Aceptor de Grupo Alcohol)/deficiencia , Sulfato Adenililtransferasa/deficiencia , Sulfato Adenililtransferasa/genéticaRESUMEN
FGF-2 exerts its pleiotropic effects on cell growth and differentiation by interacting with specific cell surface receptors. In addition, exogenously added FGF-2 is translocated from outside the cell to the nucleus during G1-S transition. In this study, we show that a single point mutation in FGF-2 (substitution of residue serine 117 by alanine) is sufficient to drastically reduce its mitogenic activity without affecting its differentiation properties. The FGF-2(S117A) mutant binds to and activates tyrosine kinase receptors and induces MAPK and p70S6K activation as strongly as the wild-type FGF-2. We demonstrate that this mutant enters NIH3T3 cells, is translocated to the nucleus, and is phosphorylated similar to the wild-type growth factor. This suggests that FGF-2 mitogenic activity may require, in addition to signaling through cell surface receptors and nuclear translocation, activation of nuclear targets. We have previously shown that, in vitro, FGF-2 directly stimulates the activity of the casein kinase 2 (CK2), a ubiquitous serine/threonine kinase involved in the control of cell proliferation. We report that, in vivo, FGF-2(WT) transiently interacts with CK2 and stimulates its activity in the nucleus during G1-S transition in NIH3T3 cells. In contrast, the FGF-2(S117A) mutant fails to interact with CK2. Thus, our results show that FGF-2 mitogenic and differentiation activities can be dissociated by a single point mutation and that CK2 may be a new nuclear effector involved in FGF-2 mitogenic activity.-Bailly, K., Soulet, F., Leroy, D., Amalric, F., Bouche, G. Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor (FGF-2).
Asunto(s)
Factor 2 de Crecimiento de Fibroblastos/farmacología , Células 3T3 , Animales , Transporte Biológico , Quinasa de la Caseína II , Bovinos , Compartimento Celular , Diferenciación Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Cricetinae , Endotelio Vascular/citología , Factor 2 de Crecimiento de Fibroblastos/genética , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Ratones , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Mitógenos/genética , Mitógenos/farmacología , Mutación , Fosforilación , Unión Proteica , Proteínas Serina-Treonina Quinasas/metabolismo , Ratas , Receptores de Factores de Crecimiento de Fibroblastos/metabolismo , Proteínas Quinasas S6 Ribosómicas , Transducción de SeñalRESUMEN
The nucleolus is a very dynamic structure able rapidly to adapt its activity to the cellular metabolic state. An interesting physiological model characterized by drastic modifications of cellular metabolism is represented by hibernating animals. In the present study we investigated the hepatocyte nuclei of euthermic and hibernating edible dormice (Glis glis) with the aim of revealing, by means of ultrastructural and immunocytochemical analyses, possible modifications of nucleolar components during hibernation. Our observations demonstrate that, in deep hibernation, nucleoli undergo structural and molecular modifications: (a) they show numerous nucleoplasmic invaginations and clumps of dense fibrillar component extend from the nucleolar surface; (b) they are frequently in contact with coiled bodies and fibro-granular material, two nuclear bodies usually occurring in the nucleoplasm; (c) the dense fibrillar component contains significant amounts of small nuclear ribonucleoproteins, splicing factors usually distributed in the nucleoplasm. Taken together, these results suggest that during hibernation complex relationships are established between the nucleolus and nucleoplasm, probably related to functional activities peculiar to this physiological phase. However, since no evident nucleolar modification was found in early hibernating dormice, it seems likely that the particular structural and molecular arrangement of nucleoli establishes progressively during hibernation, becoming evident only in the deepest phase, and then disappears upon arousal.
Asunto(s)
Nucléolo Celular/ultraestructura , Hibernación , Animales , Inmunohistoquímica , Ratones , Microscopía ElectrónicaRESUMEN
High endothelial venules (HEVs) are specialized postcapillary venules, found in lymphoid organs and chronically inflamed tissues, that support high levels of lymphocyte extravasation from the blood. Molecular characterization of HEV endothelial cells (HEVECs) has been hampered by difficulties in their purification and in vitro maintenance. To overcome these limitations, we developed a strategy combining the use of freshly purified HEVECs ( approximately 98% positive for the HEV-specific marker MECA-79) and the recently described polymerase chain reaction (PCR)-based cDNA subtraction cloning procedure called suppression subtractive hybridization (SSH). Subtracted probes prepared by SSH from small amounts of total RNA were used to screen a HEVEC cDNA library. This resulted in cloning of 22 cDNAs preferentially expressed in HEVECs, which encode the promiscuous chemokine receptor DARC, mitochondrial components, and matricellular proteins. The latter included hevin, thrombospondin-1, and mac25/IGFBP-rP1, which is a secreted growth factor-binding protein previously found to accumulate specifically in tumor blood vessels. Biochemical and histochemical analysis confirmed the identification of mac25 and DARC as novel markers of the HEVECs. Ultrastructural immunolocalization revealed a noticeable association of mac25 and MECA-79 antigens with microvillous processes near the endothelial cell junctions, suggesting a role for mac25 in the control of lymphocyte emigration. This study shows that PCR-based SSH is useful for cloning of differentially expressed genes in very small samples.
Asunto(s)
Antígenos de Protozoos , Proteínas Portadoras/metabolismo , Endotelio Vascular/metabolismo , Endotelio Vascular/ultraestructura , Proteínas de Unión a Factor de Crecimiento Similar a la Insulina , Proteínas Protozoarias , Receptores de Superficie Celular/metabolismo , Vénulas/citología , Secuencia de Aminoácidos , Antígenos de Superficie/genética , Antígenos de Superficie/metabolismo , Northern Blotting , Western Blotting , Proteínas Portadoras/genética , Quimiotaxis de Leucocito , ADN Complementario , Sistema del Grupo Sanguíneo Duffy , Endotelio Vascular/citología , Humanos , Inmunohistoquímica , Linfocitos , Proteínas de la Membrana , Mitocondrias/metabolismo , Hibridación de Ácido Nucleico , Tonsila Palatina/citología , Tonsila Palatina/metabolismo , Fenotipo , ARN/análisis , Receptores de Superficie Celular/genética , Análisis de Secuencia de ADN , Trombospondina 1/metabolismoRESUMEN
High endothelial venules (HEV) are specialized postcapillary venules found in lymphoid organs and chronically inflamed tissues that support high levels of lymphocyte extravasation from the blood. One of the major characteristics of HEV endothelial cells (HEVEC) is their capacity to incorporate large amounts of sulfate into sialomucin-type counter-receptors for the lymphocyte homing receptor L-selectin. Here, we show that HEVEC express two functional classes of sulfate transporters defined by their differential sensitivity to the anion-exchanger inhibitor 4,4'-diisothiocyanostilbene-2, 2'-disulfonic acid (DIDS), and we report the molecular characterization of a DIDS-resistant sulfate transporter from human HEVEC, designated SUT-1. SUT-1 belongs to the family of Na(+)-coupled anion transporters and exhibits 40-50% amino acid identity with the rat renal Na(+)/sulfate cotransporter, NaSi-1, as well as with the human and rat Na(+)/dicarboxylate cotransporters, NaDC-1/SDCT1 and NaDC-3/SDCT2. Functional expression studies in cRNA-injected Xenopus laevis oocytes showed that SUT-1 mediates high levels of Na(+)-dependent sulfate transport, which is resistant to DIDS inhibition. The SUT-1 gene mapped to human chromosome 7q33. Northern blotting analysis revealed that SUT-1 exhibits a highly restricted tissue distribution, with abundant expression in placenta. Reverse transcription-PCR analysis indicated that SUT-1 and the diastrophic dysplasia sulfate transporter (DTD), one of the two known human DIDS-sensitive sulfate transporters, are coexpressed in HEVEC. SUT-1 and DTD could correspond, respectively, to the DIDS-resistant and DIDS-sensitive components of sulfate uptake in HEVEC. Together, these results demonstrate that SUT-1 is a distinct human Na(+)-coupled sulfate transporter, likely to play a major role in sulfate incorporation in HEV.
Asunto(s)
Proteínas de Transporte de Anión , Proteínas Portadoras/genética , Endotelio Vascular/metabolismo , Sulfatos/metabolismo , Simportadores , Vénulas/metabolismo , Secuencia de Aminoácidos , Animales , Proteínas Portadoras/metabolismo , Células Cultivadas , Mapeo Cromosómico , Cromosomas Humanos Par 7 , Clonación Molecular , ADN Complementario , Endotelio Vascular/citología , Humanos , Datos de Secuencia Molecular , Ratas , Homología de Secuencia de Aminoácido , Sodio/metabolismo , Transportadores de Sulfato , Vénulas/citologíaRESUMEN
Dimerization is a prerequisite for many growth factors in their receptor activation leading to cellular response. FGF-1 and FGF-2, members of the Fibroblast Growth Factor (FGF) family, were shown to form non-covalent dimers and oligomers in vitro. Using the two-hybrid system as an in vivo binding assay we show here that of three representative members of the FGF family, only FGF-2 is able to homodimerize. Moreover the FGF-2 isoforms could heterodimerize. Two single-point mutants (T121F and W123R), defective in their dimerization capability, were isolated through random mutagenesis and were used to study the role of FGF-2 dimerization with regard to its biological activity. Remarkably, these mutant proteins were still able to induce cell differentiation, but were strongly affected in their capacity to promote cell proliferation. This study thus highlights the uncoupling between proliferation and differentiation FGF-2 signaling pathways and the crucial role of FGF-2 dimerization in the mitogenic activity of this factor.
Asunto(s)
Factor 2 de Crecimiento de Fibroblastos/química , Factor 2 de Crecimiento de Fibroblastos/fisiología , Animales , Células CHO , Bovinos , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , División Celular/efectos de los fármacos , División Celular/fisiología , Línea Celular , Células Cultivadas , Cricetinae , Dimerización , Factor 2 de Crecimiento de Fibroblastos/genética , Heparina/metabolismo , Mutagénesis , Células PC12 , Mutación Puntual , Unión Proteica , Conformación Proteica , Ratas , Proteínas Tirosina Quinasas Receptoras/metabolismo , Receptor Tipo 2 de Factor de Crecimiento de Fibroblastos , Receptores de Factores de Crecimiento de Fibroblastos/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacología , Transducción de Señal/fisiologíaRESUMEN
PURPOSE: Retrospective analysis of results of treatment of 132 subclinical ductal carcinomas in situ, non-palpable. MATERIAL AND METHODS: Patients were treated with limited surgery and 70 Gy radiation therapy (70 Gy). RESULTS: With a median follow-up of 7 years, the total recurrence rate was 6%, and the actuarial rate at 5 years 4% and at 10 years 13% at. These have no influence on recurrence on the specific actuarial survival rate which was 100% at 10 years. In spite of five infiltrating recurrences of seven, no metastasis appeared 48 months after the salvage surgery. The global rate of breast preservation was 92% at 7 years. DISCUSSION AND CONCLUSION: Therapeutic indications were developed taking into account the present analysis and a literature review (2,338 in situ ductal carcinomas, palpable or not, treated with conservative surgery, with or without adjuvant radio-therapy).
Asunto(s)
Neoplasias de la Mama/radioterapia , Neoplasias de la Mama/cirugía , Carcinoma in Situ/radioterapia , Carcinoma in Situ/cirugía , Carcinoma Intraductal no Infiltrante/radioterapia , Carcinoma Intraductal no Infiltrante/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Terapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
Nucleolin is one of the major nonribosomal proteins of the nucleolus. Through its four RNA-binding domains, nucleolin interacts specifically with pre-rRNA as soon as synthesis begins, but it is not found in mature cytoplasmic ribosomes. Nucleolin is able to shuttle between the cytoplasm and the nucleus. These data suggest that nucleolin might be involved in the nucleolar import of cytoplasmic components and in the assembly of pre-ribosomal particles. Here we show, using two-dimensional blots in a ligand blotting assay, that nucleolin interacts with 18 ribosomal proteins from rat (14 and 4 from the large and small subunit, respectively). The C-terminal domain of nucleolin (p50) interacts with 10 of these identified ribosomal proteins. In vitro binding assays show that the glycine-arginine rich domain of nucleolin (RGG domain) is sufficient for the interaction with one of these proteins. Interestingly, most of the proteins that interact with p50 belong to the core ribosomal proteins, which are resistant to extraction with high salt concentration. These findings suggest that nucleolin might be involved in the nucleolar targeting of some ribosomal proteins and in their assembly within pre-ribosomal particles.
Asunto(s)
Proteínas Nucleares/metabolismo , Fosfoproteínas/metabolismo , Proteínas de Unión al ARN/metabolismo , Proteínas Ribosómicas/metabolismo , Animales , Sitios de Unión , Western Blotting , Células CHO , Cricetinae , Electroforesis en Gel Bidimensional , Humanos , Unión Proteica , ARN Ribosómico/metabolismo , Ratas , NucleolinaRESUMEN
TRBP is a cellular protein that binds to the HIV-1 leader RNA, TAR. Circular dichroism experiments have shown that a 24 amino acid peptide (TR1), located within a dsRNA binding domain (dsRBD) of TRBP, binds TAR with a 3:1 stoichiometry, eliciting a conformational change involving base unstacking. The binding characteristics of synthetic structural variants of TAR indicate that guanine residues play a key role in the TR1-RNA interaction and that binding sites exist in the upper-stem/loop and lower stem region of TAR. Deletion analysis of TR1 has led to the identification of a 15 amino acid subpeptide (TR13) which is necessary and sufficient to bind to the high affinity upper-stem/loop binding site of TAR. Alanine scanning of TR13 has revealed that mutations in either Lys or Arg residues result in altered TAR-binding, and molecular modelling/docking experiments have shown that the two Arg residues of TR13 can interact with two appropriately spaced guanine residues in the upper-stem/loop of TAR. The TR13 lysine residues appear to be essential for maintaining structural integrity and the correct positioning of the Arg side-chains. We propose that TRBP binds TAR by means of a "2-G hook" motif and that the binding specificity of this particular member of the family of double-stranded RNA-binding proteins lies within the highly conserved dsRBD core motif. Finally, our results also suggest that TRBP may function in vivo by modifying the tertiary structure of TAR RNA.
Asunto(s)
Duplicado del Terminal Largo de VIH , VIH-1/química , Imitación Molecular , ARN Viral/química , Proteínas de Unión al ARN/química , Secuencia de Aminoácidos , Modelos Moleculares , Datos de Secuencia Molecular , Mutación/genética , Conformación de Ácido Nucleico , Péptidos/química , Conformación Proteica , Proteínas de Unión al ARN/metabolismo , Alineación de Secuencia , Homología de Secuencia de AminoácidoRESUMEN
High endothelial venules (HEVs) are specialized postcapillary venules found in lymphoid organs and chronically inflamed tissues that support high levels of lymphocyte extravasation from the blood. Studies with chlorate, a metabolic inhibitor of sulfation, had previously revealed that production of PAPS (3'-phosphoadenosine-5'-phosphosulfate), the high-energy donor of sulfate, is required for sulfation and high-affinity recognition of HEV sialomucins GlyCAM-1 and CD34 by the lymphocyte homing receptor L-selectin. Here, we report the molecular characterization of a novel 2.5 kb human cDNA from MECA-79+ HEV-derived endothelial cells that encodes the target of chlorate, PAPS synthetase, a multifunctional enzyme containing domains for both ATP sulfurylase and adenosine-5'-phosphosulfate kinase. Functional expression of the isolated cDNA in Chinese hamster ovary cells results in high levels of PAPS synthesis, which is abolished by treatment of the transfected cells with chlorate. Northern blot analysis reveals a wide tissue distribution of PAPS synthetase mRNA in the human body, suggesting that human PAPS synthetase may be important for sulfation not only of HEV sialomucins, but also of many other molecules, including mucins such as the P-selectin ligand PSGL-1, proteoglycans, hormones, neurotransmitters, drugs, and xenobiotics.
Asunto(s)
Complejos Multienzimáticos/biosíntesis , Sulfato Adenililtransferasa/biosíntesis , Transcripción Genética , Vénulas/enzimología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Células CHO , Cloratos/farmacología , Clonación Molecular , Secuencia de Consenso , Cricetinae , Biblioteca de Genes , Humanos , Selectina L/metabolismo , Tejido Linfoide/irrigación sanguínea , Masculino , Datos de Secuencia Molecular , Complejos Multienzimáticos/química , Especificidad de Órganos , ARN Mensajero/biosíntesis , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Sulfato Adenililtransferasa/química , TransfecciónRESUMEN
The first processing step of precursor ribosomal RNA (pre-rRNA) involves a cleavage within the 5' external transcribed spacer. This processing requires sequences downstream of the cleavage site which are perfectly conserved among human, mouse and Xenopus and also several small nucleolar RNAs (snoRNAs): U3, U14, U17 and E3. In this study, we show that nucleolin, one of the major RNA-binding proteins of the nucleolus, is involved in the early cleavage of pre-rRNA. Nucleolin interacts with the pre-rRNA substrate, and we demonstrate that this interaction is required for the processing reaction in vitro. Furthermore, we show that nucleolin interacts with the U3 snoRNP. Increased levels of nucleolin, in the presence of the U3 snoRNA, activate the processing activity of a S100 cell extract. Our results suggest that the interaction of nucleolin with the pre-rRNA substrate might be a limiting step in the primary processing reaction. Nucleolin is the first identified metazoan proteinaceous factor that interacts directly with the rRNA substrate and that is required for the processing reaction. Potential roles for nucleolin in the primary processing reaction and in ribosome biogenesis are discussed.
Asunto(s)
Fosfoproteínas/metabolismo , Precursores del ARN/metabolismo , Procesamiento Postranscripcional del ARN/fisiología , ARN Ribosómico/metabolismo , Proteínas de Unión al ARN/metabolismo , Animales , Secuencia de Bases , Secuencia Conservada/genética , Reactivos de Enlaces Cruzados , Ratones , Fosfoproteínas/química , Fosfoproteínas/farmacología , Unión Proteica , Precursores del ARN/genética , ARN Ribosómico/genética , ARN Nuclear Pequeño/genética , Proteínas de Unión al ARN/química , Proteínas de Unión al ARN/farmacología , Proteínas Recombinantes/metabolismo , Rayos Ultravioleta , NucleolinaRESUMEN
High endothelial venules (HEVs) are specialized post-capillary venules found in lymphoid tissues, that support high levels of lymphocyte extravasation from the blood. Lymphocyte L-selectin plays a key role in the initial interaction of lymphocytes with HEVs by recognizing sulfated carbohydrate ligands on HEV mucin-like glycoproteins, GlyCAM-1, CD34 and MAdCAM-1. Sulfation is key to the uniqueness of the HEV ligands since 6 or 6'-sulfated-sLe(x) isoforms have recently been identified as major capping groups of GlyCAM-1 and sulfation of both GlyCAM1 and CD34 has been shown to be required for high-affinity L-selectin binding and recognition by the HEV-specific monoclonal antibody MECA-79. To characterize the molecular mechanisms involved in the biosynthesis of sulfated L-selectin ligands in HEVs, we have started to isolate genes that play a role in sulfate metabolism in HEVs. Studies with chlorate, a selective inhibitor of the synthesis of the high energy donor of sulfate, PAPS (3'-phosphoadénosine 5'-phosphosulfate), had previously revealed that PAPS synthesis is required for sulfation of HEV ligands and recognition by L-selectin. Therefore, we screened an HEV cDNA library in order to isolate cDNAs encoding enzymes involved in PAPS synthesis. This strategy allowed us to isolate a novel cDNA encoding the PAPS synthetase from human HEVs. The molecular characteristics of PAPS synthetase and its role in biosynthesis of sulfated L-selectin ligands in HEVs are discussed.
Asunto(s)
Endotelio Linfático/metabolismo , Selectina L/metabolismo , Mucinas/biosíntesis , Animales , Secuencia de Carbohidratos , Humanos , Ligandos , Linfocitos/fisiología , Datos de Secuencia Molecular , Mucinas/metabolismo , Complejos Multienzimáticos/genética , Complejos Multienzimáticos/metabolismo , Sulfato Adenililtransferasa/genética , Sulfato Adenililtransferasa/metabolismo , Sulfatos/metabolismoRESUMEN
The interaction of nucleolin with a short stem-loop structure (NRE) requires two contiguous RNA-binding domains (RBD 1+2). The structural basis for RNA recognition by these RBDs was studied using a genetic system in Escherichia coli. Within each of the two domains, we identified several mutations that severely impair interaction with the RNA target. Mutations that alter RNA-binding specificity were also isolated, suggesting the identity of specific contacts between RBD 1+2 amino acids and nucleotides within the NRE stem-loop. Our data indicate that both RBDs participate in a joint interaction with the NRE and that each domain uses a different surface to contact the RNA. The constraints provided by these genetic data and previous mutational studies have enabled us to propose a three-dimensional model of nucleolin RBD 1+2 bound to the NRE stem-loop.